BlackRock Investment Management’s TetraLogic Pharmaceuticals Corporation TLOG Stock Holding History

BlackRock Investment Management’s Portfolio TLOG Stock Details TLOG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-1,485	Closed	–	–	4203
2016 Q1	$0	Hold	1,485	–	–	﹤0.01%	4135
2015 Q4	$3K	Hold	1,485	–	–	﹤0.01%	3987
2015 Q3	$3K	Hold	1,485	–	–	﹤0.01%	4057
2015 Q2	$3K	Buy	1,485 +817	+122%	+$2.52K	﹤0.01%	4057
2015 Q1	$3K	Hold	668	–	–	﹤0.01%	3956
2014 Q4	$3K	Hold	668	–	–	﹤0.01%	4025
2014 Q3	$3K	Hold	668	–	–	﹤0.01%	3990
2014 Q2	$4K	Sell	668 -7,512	-92%	-$42.6K	﹤0.01%	3942
2014 Q1	$52K	Buy	+8,180	New	+$73.8K	﹤0.01%	3324

Other funds holding TLOG

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return

Guggenheim Capital Chicago, Illinois $12.9B AUM 27.3% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

BlackRock Investment Management's TLOG Position: Q2 2016 in Review

BlackRock Investment Management sold out of TetraLogic Pharmaceuticals Corporation (TLOG) in Q2 2016, closing a stake of 1,485 shares.

BlackRock Investment Management first reported a position in TLOG in Q1 2014 and held it in 9 quarters. The position peaked at $52K in Q1 2014. 19 funds tracked by Wall St. Rank hold TLOG as of Q2 2016.

BlackRock Investment Management reported no remaining TetraLogic Pharmaceuticals Corporation position as of Q2 2016 after selling out during the quarter.
BlackRock Investment Management sold 1,485 TetraLogic Pharmaceuticals Corporation shares in Q2 2016.
BlackRock Investment Management first reported a position in TetraLogic Pharmaceuticals Corporation in Q1 2014 and held it in 9 quarters.
BlackRock Investment Management's TetraLogic Pharmaceuticals Corporation position peaked at $52K in Q1 2014.
19 funds tracked by Wall St. Rank held TetraLogic Pharmaceuticals Corporation as of Q2 2016.

Based on BlackRock Investment Management's 13F filing for Q2 2016, filed 10 Aug 2016.